6-162201272-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004562.3(PRKN):​c.413-20T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.923 in 1,612,738 control chromosomes in the GnomAD database, including 687,940 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.94 ( 67602 hom., cov: 33)
Exomes 𝑓: 0.92 ( 620338 hom. )

Consequence

PRKN
NM_004562.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.154

Publications

18 publications found
Variant links:
Genes affected
PRKN (HGNC:8607): (parkin RBR E3 ubiquitin protein ligase) The precise function of this gene is unknown; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in this gene are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support. [provided by RefSeq, Jul 2008]
PRKN Gene-Disease associations (from GenCC):
  • autosomal recessive juvenile Parkinson disease 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • young-onset Parkinson disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-162201272-A-G is Benign according to our data. Variant chr6-162201272-A-G is described in ClinVar as Benign. ClinVar VariationId is 259433.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKNNM_004562.3 linkc.413-20T>C intron_variant Intron 3 of 11 ENST00000366898.6 NP_004553.2 O60260-1X5DR79

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKNENST00000366898.6 linkc.413-20T>C intron_variant Intron 3 of 11 1 NM_004562.3 ENSP00000355865.1 O60260-1

Frequencies

GnomAD3 genomes
AF:
0.942
AC:
143326
AN:
152174
Hom.:
67547
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.983
Gnomad AMI
AF:
0.940
Gnomad AMR
AF:
0.942
Gnomad ASJ
AF:
0.950
Gnomad EAS
AF:
0.989
Gnomad SAS
AF:
0.902
Gnomad FIN
AF:
0.937
Gnomad MID
AF:
0.946
Gnomad NFE
AF:
0.917
Gnomad OTH
AF:
0.928
GnomAD2 exomes
AF:
0.934
AC:
234421
AN:
250952
AF XY:
0.930
show subpopulations
Gnomad AFR exome
AF:
0.984
Gnomad AMR exome
AF:
0.964
Gnomad ASJ exome
AF:
0.950
Gnomad EAS exome
AF:
0.988
Gnomad FIN exome
AF:
0.939
Gnomad NFE exome
AF:
0.918
Gnomad OTH exome
AF:
0.928
GnomAD4 exome
AF:
0.921
AC:
1345623
AN:
1460446
Hom.:
620338
Cov.:
36
AF XY:
0.921
AC XY:
668906
AN XY:
726646
show subpopulations
African (AFR)
AF:
0.985
AC:
32947
AN:
33462
American (AMR)
AF:
0.961
AC:
42959
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.948
AC:
24770
AN:
26128
East Asian (EAS)
AF:
0.979
AC:
38873
AN:
39690
South Asian (SAS)
AF:
0.896
AC:
77228
AN:
86238
European-Finnish (FIN)
AF:
0.937
AC:
50020
AN:
53384
Middle Eastern (MID)
AF:
0.930
AC:
5358
AN:
5762
European-Non Finnish (NFE)
AF:
0.916
AC:
1017441
AN:
1110710
Other (OTH)
AF:
0.928
AC:
56027
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
4997
9994
14992
19989
24986
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21496
42992
64488
85984
107480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.942
AC:
143441
AN:
152292
Hom.:
67602
Cov.:
33
AF XY:
0.942
AC XY:
70180
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.983
AC:
40832
AN:
41550
American (AMR)
AF:
0.942
AC:
14414
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.950
AC:
3298
AN:
3472
East Asian (EAS)
AF:
0.989
AC:
5119
AN:
5178
South Asian (SAS)
AF:
0.901
AC:
4348
AN:
4824
European-Finnish (FIN)
AF:
0.937
AC:
9942
AN:
10610
Middle Eastern (MID)
AF:
0.942
AC:
277
AN:
294
European-Non Finnish (NFE)
AF:
0.917
AC:
62393
AN:
68034
Other (OTH)
AF:
0.929
AC:
1961
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
447
894
1341
1788
2235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.938
Hom.:
57886
Bravo
AF:
0.944
Asia WGS
AF:
0.922
AC:
3207
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 99% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 92. Only high quality variants are reported. -

not provided Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
6.5
DANN
Benign
0.63
PhyloP100
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4709583; hg19: chr6-162622304; API